Patents by Inventor Ngan Nguyen ATKINS

Ngan Nguyen ATKINS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EPHA2 ANTIBODIES
    Publication number: 20250051464
    Abstract: Provided herein are EphA2 antibodies. These EphA2 antibodies bind preferentially to tumor tissue than normal tissue and bind to EphA2. Such antibodies are used in methods of inducing an immune response and methods of inhibiting tumor cell growth. Additionally provided are methods of producing such antibodies.
    Type: Application
    Filed: October 25, 2024
    Publication date: February 13, 2025
    Inventors: Alexander Scholz, Nikhil Vad, Michael Samuel Weiss, Anne Ye, Danhui Zhang, Iraz T. Aydin, Maryam M. Bhatti, Sean Carroll, Jessica Finn, Shuning Gai, Shaun M. Lippow, Amy Manning-Bog, Philippe Marguet, Ngan Nguyen Atkins
  • EPHA2 antibodies
    Patent number: 12162945
    Abstract: Provided herein are EphA2 antibodies. These EphA2 antibodies bind preferentially to tumor tissue than normal tissue and bind to EphA2. Such antibodies are used in methods of inducing an immune response and methods of inhibiting tumor cell growth. Additionally provided are methods of producing such antibodies.
    Type: Grant
    Filed: March 4, 2022
    Date of Patent: December 10, 2024
    Assignee: Immunome, Inc.
    Inventors: Alexander Scholz, Nikhil Vad, Michael Samuel Weiss, Anne Ye, Danhui Zhang, Iraz T. Aydin, Maryam M. Bhatti, Sean Carroll, Jessica Finn, Shuning Gai, Shaun M. Lippow, Amy Manning-Bog, Philippe Marguet, Ngan Nguyen Atkins
  • ANTIBODIES TO CORONAVIRUS SARS-COV-2
    Publication number: 20240327505
    Abstract: Described herein are antibodies or variants thereof that specifically bind to coronavirus antigens, such as SARS-CoV-2 antigens. The antibodies can be neutralizing antibodies. Also provided are methods of using the antibodies, including methods of treating a subject infected with SARS-CoV-2, and methods of diagnosing a subject infected with SARS-CoV-2.
    Type: Application
    Filed: October 20, 2022
    Publication date: October 3, 2024
    Applicants: University of Vermont and State Agricultural College, Atreca, Inc.
    Inventors: Jason Botten, Katherine L. Williams, Ngan Nguyen Atkins, Annalis Whitaker
  • ANTIBODIES TO SARS-COV-2
    Publication number: 20240301038
    Abstract: Described herein are antibodies or variants thereof that specifically bind to coronavirus antigens, such as SARS-CoV-2 antigens. The antibodies can be neutralizing antibodies. Also provided are methods of using the antibodies, including methods of treating a subject infected with SARS-CoV-2, and methods of diagnosing a subject infected with SARS-CoV-2.
    Type: Application
    Filed: March 24, 2022
    Publication date: September 12, 2024
    Applicants: Atreca, Inc., University of Vermont and State Agricultural College
    Inventors: Katherine L. Williams, Daniel Eric Emerling, Shaun M. Lippow, Ngan Nguyen Atkins, Jason Botten, Annalis Whitaker
  • ANTIBODIES TO CORONAVIRUS SARS-COV-2
    Publication number: 20240025971
    Abstract: Described herein are antibodies or variants thereof that specifically bind to coronavirus antigens, such as SARS-CoV-2 antigens. The antibodies can be neutralizing antibodies. Also provided are methods of using the antibodies, including methods of treating a subject infected with SARS-CoV-2, and methods of diagnosing a subject infected with SARS-CoV-2.
    Type: Application
    Filed: October 22, 2021
    Publication date: January 25, 2024
    Inventors: Katherine L. WILLIAMS, Daniel Eric EMERLING, Shaun M. LIPPOW, Ngan Nguyen ATKINS